Literature DB >> 26509251

Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.

Nicolas A Karakatsanis1, Yun Zhou, Martin A Lodge, Michael E Casey, Richard L Wahl, Habib Zaidi, Arman Rahmim.   

Abstract

We recently developed a dynamic multi-bed PET data acquisition framework to translate the quantitative benefits of Patlak voxel-wise analysis to the domain of routine clinical whole-body (WB) imaging. The standard Patlak (sPatlak) linear graphical analysis assumes irreversible PET tracer uptake, ignoring the effect of FDG dephosphorylation, which has been suggested by a number of PET studies. In this work: (i) a non-linear generalized Patlak (gPatlak) model is utilized, including a net efflux rate constant kloss, and (ii) a hybrid (s/g)Patlak (hPatlak) imaging technique is introduced to enhance contrast to noise ratios (CNRs) of uptake rate Ki images. Representative set of kinetic parameter values and the XCAT phantom were employed to generate realistic 4D simulation PET data, and the proposed methods were additionally evaluated on 11 WB dynamic PET patient studies. Quantitative analysis on the simulated Ki images over 2 groups of regions-of-interest (ROIs), with low (ROI A) or high (ROI B) true kloss relative to Ki, suggested superior accuracy for gPatlak. Bias of sPatlak was found to be 16-18% and 20-40% poorer than gPatlak for ROIs A and B, respectively. By contrast, gPatlak exhibited, on average, 10% higher noise than sPatlak. Meanwhile, the bias and noise levels for hPatlak always ranged between the other two methods. In general, hPatlak was seen to outperform all methods in terms of target-to-background ratio (TBR) and CNR for all ROIs. Validation on patient datasets demonstrated clinical feasibility for all Patlak methods, while TBR and CNR evaluations confirmed our simulation findings, and suggested presence of non-negligible kloss reversibility in clinical data. As such, we recommend gPatlak for highly quantitative imaging tasks, while, for tasks emphasizing lesion detectability (e.g. TBR, CNR) over quantification, or for high levels of noise, hPatlak is instead preferred. Finally, gPatlak and hPatlak CNR was systematically higher compared to routine SUV values.

Entities:  

Mesh:

Year:  2015        PMID: 26509251      PMCID: PMC4710061          DOI: 10.1088/0031-9155/60/22/8643

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  105 in total

1.  A reversible tracer analysis approach to the study of effective dopamine turnover.

Authors:  V Sossi; D J Doudet; J E Holden
Journal:  J Cereb Blood Flow Metab       Date:  2001-04       Impact factor: 6.200

Review 2.  [18F]FLT-PET in oncology: current status and opportunities.

Authors:  Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

3.  Quantitating tumor glucose metabolism with FDG and PET.

Authors:  R A Hawkins; Y Choi; S C Huang; C Messa; C K Hoh; M E Phelps
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

Review 4.  Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.

Authors:  Giampaolo Tomasi; Federico Turkheimer; Eric Aboagye
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

Review 5.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

6.  Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure.

Authors:  G Lucignani; K C Schmidt; R M Moresco; G Striano; F Colombo; L Sokoloff; F Fazio
Journal:  J Nucl Med       Date:  1993-03       Impact factor: 10.057

7.  An optimization transfer algorithm for nonlinear parametric image reconstruction from dynamic PET data.

Authors:  Guobao Wang; Jinyi Qi
Journal:  IEEE Trans Med Imaging       Date:  2012-08-08       Impact factor: 10.048

8.  Tumor metabolic rates in sarcoma using FDG PET.

Authors:  J F Eary; D A Mankoff
Journal:  J Nucl Med       Date:  1998-02       Impact factor: 10.057

9.  Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.

Authors:  Hanne Prytz; Susanne Keiding; Einar Björnsson; Ulrika Broomé; Sven Almer; Maria Castedal; Ole Lajord Munk
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

10.  Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation.

Authors:  Nicolas A Karakatsanis; Martin A Lodge; Y Zhou; Richard L Wahl; Arman Rahmim
Journal:  Phys Med Biol       Date:  2013-09-30       Impact factor: 3.609

View more
  24 in total

1.  Clinical perspectives for the use of total body PET/CT.

Authors:  Ronan Abgral; David Bourhis; Pierre-Yves Salaun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

Review 2.  Dynamic whole-body PET imaging: principles, potentials and applications.

Authors:  Arman Rahmim; Martin A Lodge; Nicolas A Karakatsanis; Vladimir Y Panin; Yun Zhou; Alan McMillan; Steve Cho; Habib Zaidi; Michael E Casey; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

3.  Relative Patlak plot for dynamic PET parametric imaging without the need for early-time input function.

Authors:  Yang Zuo; Jinyi Qi; Guobao Wang
Journal:  Phys Med Biol       Date:  2018-08-10       Impact factor: 3.609

4.  Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function.

Authors:  Guobao Wang; Michael T Corwin; Kristin A Olson; Ramsey D Badawi; Souvik Sarkar
Journal:  Phys Med Biol       Date:  2018-07-24       Impact factor: 3.609

5.  Impact of Tissue Classification in MRI-Guided Attenuation Correction on Whole-Body Patlak PET/MRI.

Authors:  Mingzan Zhuang; Nicolas A Karakatsanis; Rudi A J O Dierckx; Habib Zaidi
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

6.  Dynamic PET simulator via tomographic emission projection for kinetic modeling and parametric image studies.

Authors:  Ida Häggström; Bradley J Beattie; C Ross Schmidtlein
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

Review 7.  Towards enhanced PET quantification in clinical oncology.

Authors:  Habib Zaidi; Nicolas Karakatsanis
Journal:  Br J Radiol       Date:  2017-11-22       Impact factor: 3.039

8.  Does simplified quantitative analysis of 18F-FDG PET in cardiac inflammatory disease work?

Authors:  R Nkoulou; H Zaidi
Journal:  J Nucl Cardiol       Date:  2018-01-17       Impact factor: 5.952

9.  Structural and practical identifiability of dual-input kinetic modeling in dynamic PET of liver inflammation.

Authors:  Yang Zuo; Souvik Sarkar; Michael T Corwin; Kristin Olson; Ramsey D Badawi; Guobao Wang
Journal:  Phys Med Biol       Date:  2019-09-05       Impact factor: 3.609

10.  Does whole-body Patlak 18F-FDG PET imaging improve lesion detectability in clinical oncology?

Authors:  Guillaume Fahrni; Nicolas A Karakatsanis; Giulia Di Domenicantonio; Valentina Garibotto; Habib Zaidi
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.